Key Highlights
- Heather Simonsen appointed to Access Vascular Board of Directors.
- Simonsen brings over 20 years of experience in vascular technologies.
- AVI’s MIMIX® technology aims to eliminate IV catheter complications.
- AVI’s devices show 6 times fewer complications than standard catheters.
Source: Business Wire
Notable Quotes
- “Heather’s appointment to our board adds invaluable strategic insight and expertise. Her three decades in healthcare, including more than 20 years of experience in advancing vascular technologies from clinical stages through commercialization.” — James Biggins, President and CEO at Access Vascular
- “Access Vascular’s approach isn’t just incremental – it’s transformative. By developing catheters that the body recognizes as ‘self’ rather than foreign, we can potentially eliminate the root cause of most IV complications.” — Heather Simonsen, President and CEO at Boomerang Medical
SoHC's Take
Heather Simonsen’s appointment to the Board of Directors at Access Vascular signifies a strategic move to leverage her extensive experience in medtech, particularly in advancing vascular technologies. Her leadership at Boomerang Medical and successful ventures at PQ Bypass, Abbott, and Johnson & Johnson positions her as a valuable asset in steering AVI’s innovative MIMIX® technology towards broader clinical adoption. With AVI’s demonstrated reduction in catheter-related complications, Simonsen’s expertise is expected to accelerate the commercialization of these life-saving devices, ultimately improving patient outcomes and reducing healthcare costs. This strategic addition underscores AVI’s commitment to transformative solutions in vascular access.
